bluebird bio Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Good morning, everybody, and welcome to the Annual Bank of America Health Care Conference being conducted virtually, although we were wishing we were in Las Vegas. Hopefully, this is the last of a go-round of virtual conferences. I'm pleased to be introducing our next company presenter, bluebird bio. By the way, I'm one of the biotech analysts at BofA, I should have mentioned that. But joining us from bluebird, we've got Nick Leschly, CEO; Chip Baird, CFO; Philip Gregory, Chief Scientific Officer; and Andrew Obenshain, President of Severe Genetic Diseases. So thank you, gentlemen, for joining us.
I think maybe a good place to start. Bluebird is one of the leaders really in developing a gene therapy for sickle cell and beta thalassemia and one of the leaders in the BCMA CAR T space. A lot of the focus right now will probably be on resolution of the clinical hold pertaining to LentiGlobin.
So maybe, Nick, if you just want to start off kind of high level before. I don't want to jump right into micro level
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
